Smith, Kline & French
GlaxoSmithKline (2000–present) |
Smith, Kline & French (SKF) was an American
History
In 1830, John K. Smith opened a drugstore in Philadelphia, and his younger brother, George, joined him in 1841 to form John K Smith & Co. In 1865, Mahlon Kline joined the company, as a bookkeeper. In 1875, he took on additional responsibilities as a salesman and added many new and large accounts, as a reward the company, Mahlon K Smith and Company, was renamed into Smith, Kline and Company.[1]
In 1891, Smith, Kline and Company acquired French, Richards and Company, founded in 1844 by Clayton French and William Richards, which provided the company with a greater portfolio of consumer brands. The combined business became the Smith, Kline and French Company.[1]
In 1932, SKF chemist Gordon Alles was awarded a patent for amphetamine.[1]
In 1968, the company acquired Recherche et Industrie Thérapeutiques in Belgium.[2]
SmithKline acquired
SmithKline Beckman and
References
- ^ a b c d Glenn E. Ullyot; Barbara Hodsdon Ullyot; Leo B. Slater (2000). "The Metamorphosis of Smith-Kline & French Laboratories to Smith Kline Beecham: 1925-1998" (PDF). Bull. Hist. Chem. 25 (1). University of Illinois at Urbana-Champaign, School of Chemical Sciences. Retrieved December 16, 2017.
- ^ "Gates Foundation Finances Leuven University Research for Coronavirus Treatment". The Low Countries. 26 March 2020. Retrieved 20 February 2023.
- ISSN 0362-4331. Retrieved 25 June 2020.